Search

Author/Creator Jones, Rob J.

1. Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476). Issue 3 (16th May 2022)

Authors:
James, Nicholas D.; Clarke, Noel W.; Cook, Adrian; Ali, Adnan; Hoyle, Alex P.; Attard, Gerhardt; Brawley, Christopher D.; Chowdhury, Simon; Cross, William R.; Dearnaley, David P.; de Bono, Johann S.; Diaz‐Montana, Carlos; Gilbert, Duncan; Gillessen, Silke; Gilson, Clare; Jones, Rob J.; Langley, R...
Journal:
International journal of cancer
Issue:
Volume 151:Issue 3(2022)
Page Start:
422
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Final quality of life and safety data for patients with metastatic castration‐resistant prostate cancer treated with cabazitaxel in the UK Early Access Programme (EAP) (NCT01254279). (16th June 2015)

Authors:
Bahl, Amit; Masson, Susan; Malik, Zafar; Birtle, Alison J.; Sundar, Santhanam; Jones, Rob J.; James, Nicholas D.; Mason, Malcolm D.; Kumar, Satish; Bottomley, David; Lydon, Anna; Chowdhury, Simon; Wylie, James; de Bono, Johann S.
Journal:
BJU international
Issue:
Volume 116:Number 6(2015:Dec.)
Page Start:
880
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search